Market Flash

Recently, the domestic PVC spot and futures markets have turned sharply down, both futures and spot prices have fallen

• PVC

In recent years, the domestic propylene industry has developed rapidly. In 2019, the new domestic propylene production capacity reached 3.66 Mt, a year-on-year increase of 10.6%.

• PDH
• Propylene capacity

On April 25, Renfu Pharma announced that the clinical application for the Class 1 new drug RFUS-144 injection of its holding subsidiary Yichang Renfu was accepted by CDE.

• opiod Painkillers
• clinical

In April, the overall domestic liquefied gas market fluctuated frequently, but the range was limited, and the overall focus of the Shandong civil gas market moved up slightly.

• liquefied gas
• LPG

The latest March report released by ANRPC predicts that global natural rubber production in 2022 is expected to increase by 2.3% year-on-year to 14.292 million tons.

• natural rubber

Florfenicol is actively exploring prices, manufacturers are reluctant to sell it, and the market price is 430-445.

• Tetracycline
• Chloramphenicol

A few days ago, the official website of the Center for Drug Evaluation of the State Food and Drug Administration announced that the marketing application of the HER2-targeting antibody-drug conjugate

• breast cancer

On April 25, Qilu Pharmaceutical announced that the submitted application for marketing authorization of aflibercept intraocular injection solution was accepted by the Center for Drug Evaluation of the State Food and Drug Administration.

• Qilu Pharmaceutical
• Aflibercept

On April 26, according to CDE's official website, Henlius' Class 1 new drug HLX53 was submitted for clinical application.

• Henlius
• Antibody Drug

Pharmaceutical excipients belong to the pharmaceutical manufacturing fine-molecule industry, so the growth of the excipient market is positively correlated with the growth of the pharmaceutical industry.

• Pharmaceutical excipient

On April 25, Hengrui announced that its subsidiary Beijing Shengdi Pharmaceutical's class 1 new drug SHR-2004 injection was approved for clinical use

• Hengrui medicine
• Antithrombotic drug

On April 25, Arrowhead Pharmaceuticals announced that it had formed a joint venture with Vivo Capital, Visirna Therapeutics, which will be headquartered in Shanghai.

• vivo capital
• Pharmaceuticals

Potential targets with clinical advantages are the targets that innovative drug R&D companies are looking for. However, in the face of today's global new drug research and development situation

• NAMPT
• tumor

In addition to the difficulty of personnel arriving at the post, logistics and transportation are still a problem that cannot be ignored.

• shipping
• transportation

Here you will find a wide range of market prices and insights on vitamin products in China. We focus on collecting valid information such as China domestic prices

• vitamin market
• chemical information

This week, the zinc market rose first and then fell. As of April 24, the zinc price was 28,494 CNY/ton, an increase of 1.51% from the 28,070 CNY/ton zinc price on April 17 last weekend.

• zinc

Recently, export purchase orders have dropped significantly, and container spot freight rates are also facing increasing pressure.

• Shipping

Rystad, a Norwegian energy consultancy, said recently that soaring oil, gas and electricity prices, coupled with the European Union's reduced dependence on Russia for supplies and the impact of the new crown pneumonia epidemic

• global energy

Neomycin for veterinary use, kanamycin and gentamicin are all aminoglycoside antibiotics, and neomycin sulfate soluble powder is currently the most widely used in veterinary clinical treatment.

• Neomycin sulfate
• Amoxicillin

In recent years, the rare disease market has continued to heat up. According to Frost & Sullivan, the global rare disease drug market will increase from US$135.1 billion in 2020 to US$383.3 billion in 2030

• rare disease
• pharmaceutical